Higgons John Duncan

Insider profile

Higgons John Duncan's trades of Jounce Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
77.16
Quantity 54,529 +20.2%
Value US$2,309,969
Transaction date
Planned sale
Price
451.69
Quantity 85,592 +1.2%
Value US$1,504,498
Transaction date
Planned sale
Price
122.81
Quantity 51,231 -34.1%
Value US$3,686,104
Transaction date
Planned sale
Price
12.00
Quantity 1,500 -12.5%
Value US$18,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-04-16 2021-04-15
PlS Planned sale
54,529 +20.2%
77.16
US$2,309,969 		54,529 +20.2% 77.16 US$2,309,969
2021-03-17 2021-03-15
PlS Planned sale
85,592 +1.2%
451.69
US$1,504,498 		85,592 +1.2% 451.69 US$1,504,498
2021-02-18 2021-02-16
PlS Planned sale
51,231 -34.1%
122.81
US$3,686,104 		51,231 -34.1% 122.81 US$3,686,104
2021-01-22 2021-01-21
PlS Planned sale
200 -1.9%
11.11
US$2,222 		200 -1.9% 11.11 US$2,222
2021-01-22 2021-01-20
PlS Planned sale
1,500 -12.5%
12.00
US$18,000 		1,500 -12.5% 12.00 US$18,000
2020-01-08 2020-01-06
PlS Planned sale
1,500 -11.1%
8.11
US$12,165 		1,500 -11.1% 8.11 US$12,165